J 2017

Intertumoral Heterogeneity within Medulloblastoma Subgroups

CAVALLI, F.M.G., M. REMKE, L. RAMPASEK, J. PEACOCK, D.J.H. SHIH et. al.

Basic information

Original name

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Authors

CAVALLI, F.M.G. (124 Canada), M. REMKE (124 Canada), L. RAMPASEK (124 Canada), J. PEACOCK (124 Canada), D.J.H. SHIH (124 Canada), B. LUU (124 Canada), L. GARZIA (124 Canada), J. TORCHIA (124 Canada), C. NOR (124 Canada), A.S. MORRISSY (124 Canada), S. AGNIHOTRI (840 United States of America), Y.Y. THOMPSON (124 Canada), C.M. KUZAN-FISCHER (124 Canada), H. FAROOQ (124 Canada), K. ISAEV (124 Canada), C. DANIELS (124 Canada), B.K. CHO (410 Republic of Korea), S.K. KIM (410 Republic of Korea), K.C. WANG (410 Republic of Korea), J.Y. LEE (410 Republic of Korea), W.A. GRAJKOWSKA (840 United States of America), M. PEREK-POLNIK (616 Poland), A. VASILJEVIC (250 France), C. FAURE-CONTER (250 France), A. JOUVET (250 France), C. GIANNINI (840 United States of America), A.A.N. RAO (840 United States of America), K.K.W. LI (156 China), H.K. NG (156 China), C.G. EBERHART (840 United States of America), I.F. POLLACK (840 United States of America), R.L. HAMILTON (840 United States of America), G.Y. GILLESPIE (840 United States of America), J.M. OLSON (840 United States of America), S. LEARY (840 United States of America), W.A. WEISS (840 United States of America), B. LACH (124 Canada), L.B. CHAMBLESS (840 United States of America), R.C. THOMPSON (840 United States of America), M.K. COOPER (840 United States of America), R. VIBHAKAR (840 United States of America), P. HAUSER (348 Hungary), M.L.C. van VEELEN (528 Netherlands), J.M. KROS (528 Netherlands), P.J. FRENCH (528 Netherlands), Y.S. RA (410 Republic of Korea), T. KUMABE (392 Japan), E. LOPEZ-AGUILAR (484 Mexico), Karel ZITTERBART (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, guarantor, belonging to the institution), G. FINOCCHIARO (380 Italy), M. MASSIMINO (380 Italy), E.G. VAN MEIR (840 United States of America), S. OSUKA (840 United States of America), T. SHOFUDA (392 Japan), A. KLEKNER (348 Hungary), M. ZOLLO (380 Italy), J.R. LEONARD (840 United States of America), J.B. RUBIN (840 United States of America), N. JABADO (124 Canada), S. ALBRECHT (124 Canada), J. MORA (724 Spain), T.E. VAN METER (840 United States of America), S. JUNG (410 Republic of Korea), A.S. MOORE (36 Australia), A.R. HALLAHAN (36 Australia), J.A. CHAN (124 Canada), D.C. TIRAPELI (76 Brazil), C.G. CARLOTTO (76 Brazil), M. FOULADI (840 United States of America), J. PIMENTEL (620 Portugal), C.C. FARIA (620 Portugal), A.G. SAAD (840 United States of America), L. MASSIMI (380 Italy), L.M. LIAU (840 United States of America), H. WHEELER (36 Australia), H. NAKAMURA (392 Japan), S.K. ELBABAA (840 United States of America), M. PEREZPENA DIAZCONTI (484 Mexico), F.C. PONCE DE LEÓN (484 Mexico), S. ROBINSON (840 United States of America), M. ZAPOTOCKY (124 Canada), A. LASSALETTA (124 Canada), A. HUANG (124 Canada), C.E. HAWKINS (124 Canada), U. TABORI (124 Canada), E. BOUFFET (124 Canada), U. BARTELS (124 Canada), P.B. DIRKS (124 Canada), J.T. RUTKA (124 Canada), G.D. BADER (124 Canada), J. REIMAND (124 Canada), A. GOLDENBERG (124 Canada), V. RAMASWAMY (124 Canada) and M.D. TAYLOR (124 Canada)

Edition

Cancer Cell, Cambridge, Cell Press, 2017, 1535-6108

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 22.844

RIV identification code

RIV/00216224:14110/17:00098842

Organization unit

Faculty of Medicine

UT WoS

000403074800005

Keywords in English

Intertumoral Heterogeneity

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 15:07, Soňa Böhmová

Abstract

V originále

While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to genome-wide DNA methylation and gene expression data across 763 primary samples identifies very homogeneous clusters of patients, supporting the presence of medulloblastoma subtypes. After integration of somatic copy-number alterations, and clinical features specific to each cluster, we identify 12 different subtypes of medulloblastoma. Integrative analysis using SNF further delineates group 3 from group 4 medulloblastoma, which is not as readily apparent through analyses of individual data types. Two clear subtypes of infants with Sonic Hedgehog medulloblastoma with disparate outcomes and biology are identified. Medulloblastoma subtypes identified through integrative clustering have important implications for stratification of future clinical trials.

Links

EE2.3.20.0183, research and development project
Name: Centrum experimentální biomedicíny